Endoscopic device for tumor ablation via ERCP using radiofrequency energy in patients with advanced and inoperable pancreatic cancer and cholangiocarcinoma
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of EMcision (Acquired) plus 4717 other start-ups.
